Exon-skipping drug approved for the third subtype of Duchenne muscular dystrophy
Discovering treatments for Duchenne muscular dystrophy has been difficult because the disease is a result of a wide variety...
FDA
US FDA Approves Midostaurin for Treatment of Acute Myeloid Leukemia
The US FDA approved the use of Rydapt (midostaurin) in combination with chemotherapy for treating recently diagnosed adults with...
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) by the FDA
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is not breast cancer but a rare type of T-cell lymphoma that...
FDA Issues Warning Regarding the Use of Balloon Angioplasty For Treatment Of Autonomic Dysfunction Disorders
US Food and Drug Administration (FDA) has warned both patients and doctors alike about the use of balloon angioplasty...
FDA gives a green signal for maintenance treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer with Niraparib
Adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who have responded completely or partially to...
FDA Approves Epclusa: A New Drug That Treats All Genotypes Of Hepatitis C Infection
US Food and Drug Administration has approved Epclusa an oral, fixed-dose combination drug for adults, containing sofosbuvir 400 mg...
FDA Approves Balloon Dilatation For Eustachian Tube Dysfunction
The US Food and Drug Administration has now permitted sale of a device that uses a small balloon to...
FDA ALERT REGARDING RISKS ASSOCIATED WITH OVARIAN CANCER SCREENING TESTS
Ovarian cancer is the sixth most commonly diagnosed cancer worldwide. Second, only to uterine cancer, it is a leading...
FDA grants accelerated approval to the first drug for Duchenne muscular dystrophy
The FDA has approved a new drug, Exondys 51, manufactured by Sarepta Therapeutics that targets exon 51 skipping. This...